Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

Sarcoidosis is an inflammatory disease characterized by the formation of granulomas in one or more organs of the body. When left unchecked, chronic inflammation caused by granulomas can lead to ...

These can cluster in the organs of the body, typically the lungs and lymph nodes, but also affecting the eyes, skin, heart, and nervous system. The Foundation for Sarcoidosis Research estimates ...

Mortality rates among United States veterans with sarcoidosis have been rising since 2004, most notably in men, according to study findings published in Chest. Investigators studied the trends in ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and LONDON ...

As devastating wildfires and smoke sweep across California, the Foundation for Sarcoidosis Research (FSR) urges individuals to prioritize their immediate and long-term health ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and LONDON ...

Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosis Further development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Interstitial Lung Disease ...